Virtus Biotech ETF
13 hedge funds and large institutions have $4.45M invested in Virtus Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
3% more capital invested
Capital invested by funds: $4.32M → $4.45M (+$131K)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
7% less funds holding
Funds holding: 14 → 13 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$586K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$236K |
| 3 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
+$140K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$98.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$592K |
| 2 |
LPL Financial
San Diego,
California
|
-$74.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$41K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$926 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1.44M | +$98.8K | +3,199 | +8% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $950K | -$592K | -19,162 | -40% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $633K | +$586K | +18,961 | New |
|
|
4
Stifel Financial
St. Louis,
Missouri
| $611K | +$236K | +7,650 | +72% |
|
|
5
LPL Financial
San Diego,
California
| $567K | -$74.4K | -2,409 | -12% |
|
|
MFS
6
MSI Financial Services
Springfield,
Massachusetts
| $157K | +$140K | +4,546 | +2,991% |
|
|
FWM
7
Focused Wealth Management
Newburgh,
New York
| $33K | – | – | – |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $22K | – | – | – |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $18K | – | – | – |
|
|
CFA
10
Carroll Financial Associates
Charlotte,
North Carolina
| $8K | – | – | – |
|
11
Creative Planning
Overland Park,
Kansas
| $7K | – | – | – |
|
12
Morgan Stanley
New York
| $3K | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $2K | -$926 | -30 | -30% |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$41K | -1,538 | Closed |
|
BBP Hedge Fund Activity: Q3 2016 in Review
13 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2016, worth a combined $4.45M — up 3% from $4.32M a quarter earlier.
Fund positioning in BBP was balanced in Q3 2016: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $586K. The largest seller was Susquehanna International Group, cutting an estimated $592K.
- 13 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2016, down from 14 in Q2 2016.
- Funds reported $4.45M of Virtus Biotech ETF stock for Q3 2016, up 3% quarter-over-quarter.
- 1 fund opened new Virtus Biotech ETF positions in Q3 2016 and 1 closed out, a net change of 0 holders.
- The largest Virtus Biotech ETF buyer in Q3 2016 was Virtu KCG Holdings, an estimated $586K added.
- The largest Virtus Biotech ETF seller in Q3 2016 was Susquehanna International Group, an estimated $592K sold.
Based on aggregated 13F filings for Q3 2016.